Evidence mapPaperPMID 33604759Full record

GuidelineVirchows Archiv : an international journal of pathology2021

ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.

Nicole Concin, Carien L Creutzberg, Ignace Vergote, David Cibula, Mansoor Raza Mirza, Simone Marnitz, Jonathan A Ledermann, Tjalling Bosse, Cyrus Chargari, Anna Fagotti and 18 more

Abstract readConsensus StatementPractice GuidelineSystematic Review
PubMed Publisher
In one paragraph

Guideline in Virchows Archiv : an international journal of pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed, 6 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Spanish Society for Radiation Oncology and Spanish Society of Medical Physicists recommendations on reirradiation in gynecological cancer: reirradiation techniques, survival outcomes, dose, and toxicity.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Guideline
  2. Pooled it
  3. Pooled it
  4. Gender bias in shared decision-making among cancer care guidelines: A systematic review.Health expectations : an international journal of public participation in health care and health policy · 2023
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Nicole ConcinDepartment of Gynecology and Obstetrics, Innsbruck Medical University, Innsbruck, Austria. nicole.concin@i-med.ac.at.
Carien L CreutzbergDepartment of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.
Ignace VergoteDepartment of Gynecology and Obstetrics, Gynecologic Oncology, Leuven Cancer Institute, Catholic University Leuven, Leuven, Belgium.
David CibulaDepartment of Obstetrics and Gynecology, First Faculty of Medicine, Charles University, General University Hospital in Prague, Prague, Czech Republic.
Mansoor Raza MirzaDepartment of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Simone MarnitzDepartment of Radiation Oncology, Medical Faculty of the University of Cologne, Cologne, Germany.
Jonathan A LedermannUCL Cancer Institute, University College, London, UK.
Tjalling BosseDepartment of Pathology, Leids Universitair Medisch Centrum, Leiden, The Netherlands.
Cyrus ChargariDepartment of Radiation Oncology, Institut Gustave Roussy, Villejuif, France.
Anna FagottiDivision of Gynecologic Oncology, Fondazione Policlinico Universitario A Gemelli IRCCS, Roma, Italy.
Christina FotopoulouDepartment of Gynaecologic Oncology, Imperial College London Faculty of Medicine, London, UK.
Antonio González-MartínDepartment of Medical Oncology, Clinica Universidad de Navarra, Madrid, Spain.
Sigurd F LaxDepartment of Pathology, Hospital Graz II, Graz, Austria.
Domenica LorussoDivision of Gynecologic Oncology, Fondazione Policlinico Universitario A Gemelli IRCCS, Roma, Italy.
Christian MarthDepartment of Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, Austria.
Philippe MoriceDepartment of Surgery, Institut Gustave Roussy, Villejuif, France.
Remi A NoutDepartment of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Dearbhaile E O'DonnellDepartment of Medical Oncology, St. James Hospital, Dublin, Ireland.
Denis QuerleuDivision of Gynecologic Oncology, Fondazione Policlinico Universitario A Gemelli IRCCS, Roma, Italy.
Maria Rosaria RaspolliniHistopathology and Molecular Diagnostics, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.
Jalid SehouliDepartment of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Alina E SturdzaDepartment of Radiation Oncology, Comprehensive Cancer Center, Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna, Vienna, Austria.
Alexandra TaylorDepartment of Gynaecology, Royal Marsden Hospital, London, UK.
Anneke M WestermannDepartment of Medical Oncology, Amsterdam University Medical Centres, Amsterdam, Noord-Holland, The Netherlands.
Pauline WimbergerDepartment of Gynecology and Obstetrics, TU Dresden Medizinische Fakultat Carl Gustav Carus, Dresden, Germany.
Nicoletta ColomboGynecologic Oncology Program, European Institute of Oncology, IRCCS, Milan and University of Milan-Bicocca, Milan, Italy.
François PlanchampClinical research Unit, Institut Bergonie, Bordeaux, France.
Xavier Matias-GuiuDepartment of Pathology, Hospital Universitari Arnau de Vilanova, University of Lleida, CIBERONC, Irblleida, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A European consensus conference on endometrial carcinoma was held in 2014 to produce multidisciplinary evidence-based guidelines on selected questions. Given the large body of literature on the management of endometrial carcinoma published since 2014, the European Society of Gynaecological Oncology (ESGO), the European SocieTy for Radiotherapy & Oncology (ESTRO) and the European Society of Pathology (ESP) jointly decided to update these evidence-based guidelines and to cover new topics in order to improve the quality of care for women with endometrial carcinoma across Europe and worldwide. ESGO/ESTRO/ESP nominated an international multidisciplinary development group consisting of practicing clinicians and researchers who have demonstrated leadership and expertise in the care and research of endometrial carcinoma (27 experts across Europe). To ensure that the guidelines are evidence-based, the literature published since 2014, identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group. The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 191 independent international practitioners in cancer care delivery and patient representatives. The guidelines comprehensively cover endometrial carcinoma staging, definition of prognostic risk groups integrating molecular markers, pre- and intra-operative work-up, fertility preservation, management for early, advanced, metastatic, and recurrent disease and palliative treatment. Principles of radiotherapy and pathological evaluation are also defined.

Indexed as

Biomarkers, TumorBiopsyCarcinomaEndometrial NeoplasmsEvidence-Based MedicineFemaleHumansMedical OncologyMolecular Diagnostic TechniquesNeoplasm StagingPredictive Value of TestsRisk AssessmentRisk FactorsTreatment OutcomeBiomarkers, TumorEndometrial carcinomaGuidelinesManagementMolecular markersStaging

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.